Participants 110 170 4
patients with hormonally untreated carcinoma of the prostate
Participants 367 455 4
patients with hormonally untreated carcinoma of the prostate and rising serum PSA levels
Participants 465 480 5
Eighty patients
Participants 964 1023 3
Seventy patients completed the study (36 verum; 34 placebo)
